Symbols / EKSO $10.03 -1.18% Ekso Bionics Holdings, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
EKSO Chart
About

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Instruments & Su Market Cap 35.74M
Enterprise Value 39.64M Income -11.92M Sales 12.80M
Book/sh 2.54 Cash/sh 0.33 Dividend Yield —
Payout 0.00% Employees 50 IPO —
P/E — Forward P/E -52.79 PEG —
P/S 2.79 P/B 3.96 P/C —
EV/EBITDA -3.60 EV/Sales 3.10 Quick Ratio 0.98
Current Ratio 1.63 Debt/Eq 51.45 LT Debt/Eq —
EPS (ttm) -4.91 EPS next Y -0.19 EPS Growth —
Revenue Growth -38.30% Earnings 2026-05-04 ROA -33.62%
ROE -107.62% ROIC — Gross Margin 53.48%
Oper. Margin -119.71% Profit Margin -91.37% Shs Outstand 3.56M
Shs Float 2.64M Short Float 7.62% Short Ratio 2.08
Short Interest — 52W High 13.50 52W Low 2.73
Beta 0.84 Avg Volume 2.20M Volume 26.11K
Target Price $9.50 Recom None Prev Close $10.15
Price $10.03 Change -1.18%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.50
Mean price target
2. Current target
$10.03
Latest analyst target
3. DCF / Fair value
$-22.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.03
Low
$9.50
High
$9.50
Mean
$9.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-31 down HC Wainwright & Co. Buy → Neutral —
2025-11-18 main HC Wainwright & Co. Buy → Buy $6
2025-07-29 main Lake Street Buy → Buy $10
2025-05-06 main HC Wainwright & Co. Buy → Buy $4
2025-03-04 main Lake Street Buy → Buy $1
2025-03-04 reit HC Wainwright & Co. Buy → Buy $9
2025-01-14 reit HC Wainwright & Co. Buy → Buy $9
2024-10-29 main Lake Street Buy → Buy $2
2024-10-29 main HC Wainwright & Co. Buy → Buy $9
2024-07-30 reit HC Wainwright & Co. Buy → Buy $10
2024-06-24 init Lake Street — → Buy $3
2024-04-30 main HC Wainwright & Co. Buy → Buy $10
2024-03-05 main HC Wainwright & Co. Buy → Buy $9
2024-01-22 main HC Wainwright & Co. Buy → Buy $10
2023-04-28 reit HC Wainwright & Co. — → Buy $9
2023-03-30 reit HC Wainwright & Co. — → Buy $9
2022-07-29 main HC Wainwright & Co. — → Buy $9
2020-10-30 main HC Wainwright & Co. — → Buy $11
2020-08-03 main Aegis Capital — → Buy $9
2020-06-26 main HC Wainwright & Co. — → Buy $12
News
RSS: Latest EKSO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-16 JONES JASON C Chief Operating Officer — 1,308 $11.85 $15,500
2026-03-16 WONG JEROME Chief Financial Officer — 1,308 $11.85 $15,500
2026-02-19 ASHER DANIEL Beneficial Owner of more than 10% of a Class of Security — 1,200 $12.30 $14,760
2026-02-19 ASHER DANIEL Beneficial Owner of more than 10% of a Class of Security — 15,540 $12.30 $191,162
2026-02-13 ASHER DANIEL Beneficial Owner of more than 10% of a Class of Security — 102,029 $8.96 $970,069
2026-01-06 JONES JASON C Chief Operating Officer — 1,320 $9.25 $12,210
2025-12-09 JONES JASON C Chief Operating Officer — 270 $4.70 $1,269
2025-12-09 WONG JEROME Chief Financial Officer — 1,238 $4.70 $5,819
2025-11-10 DAVIS SCOTT GERALD Chief Executive Officer — 23,315 $4.80 $111,912
2025-11-10 JONES JASON C Chief Operating Officer — 9,723 $4.80 $46,670
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
12.80
-28.60%
17.93
-1.94%
18.28
+41.57%
12.91
Operating Revenue
12.52
-26.24%
16.97
-5.30%
17.92
+50.35%
11.92
Cost Of Revenue
5.95
-29.24%
8.41
-8.54%
9.20
+37.35%
6.70
Reconciled Cost Of Revenue
5.95
-29.24%
8.41
-8.54%
9.20
+37.35%
6.70
Gross Profit
6.84
-28.03%
9.51
+4.76%
9.08
+46.11%
6.21
Operating Expense
20.17
+1.00%
19.97
-17.44%
24.19
+11.12%
21.77
Research And Development
3.03
-21.76%
3.87
-22.91%
5.03
+38.58%
3.63
Selling General And Administration
17.14
+6.48%
16.10
-16.01%
19.17
+5.63%
18.14
Selling And Marketing Expense
7.15
-2.11%
7.31
-13.74%
8.47
+18.37%
7.16
General And Administrative Expense
9.99
+13.62%
8.79
-17.81%
10.69
-2.67%
10.99
Other Gand A
9.99
+13.62%
8.79
-17.81%
10.69
-2.67%
10.99
Total Expenses
26.12
-7.96%
28.39
-14.99%
33.39
+17.29%
28.47
Operating Income
-13.33
-27.40%
-10.46
+30.78%
-15.11
+2.85%
-15.56
Total Operating Income As Reported
-13.33
-27.40%
-10.46
+30.78%
-15.11
+2.85%
-15.56
EBITDA
-9.81
-3.81%
-9.45
+28.38%
-13.20
+5.98%
-14.04
Normalized EBITDA
-11.78
-33.05%
-8.85
+34.31%
-13.48
+8.31%
-14.70
Reconciled Depreciation
1.57
-2.18%
1.61
-5.30%
1.70
+91.43%
0.89
EBIT
-11.39
-2.94%
-11.06
+25.75%
-14.90
+0.19%
-14.92
Total Unusual Items
1.97
+427.67%
-0.60
-315.05%
0.28
-57.85%
0.66
Total Unusual Items Excluding Goodwill
1.97
+427.67%
-0.60
-315.05%
0.28
-57.85%
0.66
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
—
—
—
Restructuring And Mergern Acquisition
—
—
—
—
Net Income
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Pretax Income
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Net Non Operating Interest Income Expense
-0.31
-14.87%
-0.27
+10.93%
-0.30
-93.59%
-0.16
Interest Expense Non Operating
0.31
+14.87%
0.27
-10.93%
0.30
+93.59%
0.16
Net Interest Income
-0.31
-14.87%
-0.27
+10.93%
-0.30
-93.59%
-0.16
Interest Expense
0.31
+14.87%
0.27
-10.93%
0.30
+93.59%
0.16
Other Income Expense
1.94
+422.80%
-0.60
-378.24%
0.22
-65.82%
0.63
Other Non Operating Income Expenses
-0.03
-2500.00%
-0.00
+98.41%
-0.06
-110.00%
-0.03
Gain On Sale Of Security
1.97
+427.67%
-0.60
-315.05%
0.28
-57.85%
0.66
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Net Income From Continuing Operation Net Minority Interest
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Net Income From Continuing And Discontinued Operation
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Net Income Continuous Operations
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Normalized Income
-13.66
-27.32%
-10.73
+30.67%
-15.48
+1.68%
-15.74
Net Income Common Stockholders
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Diluted EPS
-4.91
+41.55%
-8.40
+49.09%
-16.50
+5.17%
-17.40
Basic EPS
-4.91
+41.55%
-8.40
+49.09%
-16.50
+5.17%
-17.40
Basic Average Shares
2.43
+80.50%
1.34
+45.39%
0.92
+6.98%
0.86
Diluted Average Shares
2.43
+80.50%
1.34
+45.39%
0.92
+6.98%
0.86
Diluted NI Availto Com Stockholders
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Average Dilution Earnings
—
—
—
0.00
Line Item Trend 2023-12-31
Total Assets
28.92
Current Assets
20.21
Cash Cash Equivalents And Short Term Investments
8.64
Cash And Cash Equivalents
8.64
Cash Financial
8.64
Receivables
5.64
Accounts Receivable
5.64
Gross Accounts Receivable
5.72
Allowance For Doubtful Accounts Receivable
-0.08
Inventory
5.05
Raw Materials
4.30
Work In Process
0.29
Finished Goods
0.46
Prepaid Assets
—
Restricted Cash
—
Other Current Assets
0.88
Total Non Current Assets
8.71
Net PPE
2.99
Gross PPE
6.15
Accumulated Depreciation
-3.16
Properties
0.00
Machinery Furniture Equipment
3.58
Other Properties
2.40
Leases
0.18
Goodwill And Other Intangible Assets
5.32
Goodwill
0.43
Other Intangible Assets
4.89
Other Non Current Assets
0.39
Total Liabilities Net Minority Interest
16.31
Current Liabilities
8.12
Payables And Accrued Expenses
4.51
Payables
1.85
Accounts Payable
1.85
Current Accrued Expenses
2.66
Current Debt And Capital Lease Obligation
1.61
Current Debt
1.25
Other Current Borrowings
1.25
Current Capital Lease Obligation
0.36
Current Deferred Liabilities
1.99
Current Deferred Revenue
1.99
Total Non Current Liabilities Net Minority Interest
8.20
Long Term Debt And Capital Lease Obligation
5.55
Long Term Debt
4.83
Long Term Capital Lease Obligation
0.72
Non Current Deferred Liabilities
2.17
Non Current Deferred Revenue
2.17
Other Non Current Liabilities
0.10
Stockholders Equity
12.61
Common Stock Equity
12.61
Capital Stock
0.01
Common Stock
0.01
Preferred Stock
0.00
Share Issued
0.99
Ordinary Shares Number
0.99
Treasury Shares Number
0.00
Additional Paid In Capital
251.58
Retained Earnings
-239.15
Gains Losses Not Affecting Retained Earnings
0.16
Other Equity Adjustments
0.16
Total Equity Gross Minority Interest
12.61
Total Capitalization
17.44
Working Capital
12.09
Invested Capital
18.69
Total Debt
7.17
Net Debt
—
Capital Lease Obligations
1.09
Net Tangible Assets
7.28
Tangible Book Value
7.28
Derivative Product Liabilities
0.37
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-11.80
-19.86%
-9.85
+18.32%
-12.05
+17.93%
-14.69
Cash Flow From Continuing Operating Activities
-11.80
-19.86%
-9.85
+18.32%
-12.05
+17.93%
-14.69
Net Income From Continuing Operations
-11.70
-3.22%
-11.33
+25.45%
-15.20
-0.78%
-15.08
Depreciation Amortization Depletion
1.57
-2.18%
1.61
-5.30%
1.70
+91.43%
0.89
Depreciation
—
—
—
—
Depreciation And Amortization
1.57
-2.18%
1.61
-5.30%
1.70
+91.43%
0.89
Other Non Cash Items
—
—
—
-0.02
Stock Based Compensation
1.62
-0.31%
1.63
-27.10%
2.24
-18.16%
2.73
Provisionand Write Offof Assets
-0.05
-129.24%
0.17
+137.50%
0.07
+118.18%
0.03
Asset Impairment Charge
0.75
0.00
—
—
Operating Gains Losses
-1.97
-427.67%
0.60
+315.05%
-0.28
+57.85%
-0.66
Gain Loss On Investment Securities
-0.00
+99.73%
-0.36
-374.44%
0.13
+110.10%
-1.32
Net Foreign Currency Exchange Gain Loss
-1.97
-303.63%
0.96
+334.22%
-0.41
-162.90%
0.66
Change In Working Capital
-2.04
+19.29%
-2.52
-333.10%
-0.58
+77.40%
-2.58
Change In Receivables
0.45
+122.67%
-1.97
-62.83%
-1.21
-1702.99%
-0.07
Changes In Account Receivables
0.45
+122.67%
-1.97
-62.83%
-1.21
-1702.99%
-0.07
Change In Inventory
-0.28
-207.00%
0.26
+10.78%
0.23
+116.57%
-1.40
Change In Prepaid Assets
-0.19
-156.84%
0.33
+308.23%
-0.16
+47.85%
-0.30
Change In Payables And Accrued Expense
-1.24
-39.68%
-0.89
+38.45%
-1.44
-381.94%
-0.30
Change In Accrued Expense
-1.10
-83.97%
-0.60
-347.01%
-0.13
+31.98%
-0.20
Change In Payable
-0.14
+52.43%
-0.29
+77.96%
-1.31
-1181.37%
-0.10
Change In Account Payable
-0.14
+52.43%
-0.29
+77.96%
-1.31
-1181.37%
-0.10
Change In Other Working Capital
-0.78
-204.67%
-0.26
-112.90%
1.99
+489.82%
-0.51
Investing Cash Flow
-0.19
-408.11%
-0.04
+76.43%
-0.16
+96.97%
-5.17
Cash Flow From Continuing Investing Activities
-0.19
-408.11%
-0.04
+76.43%
-0.16
+96.97%
-5.17
Net PPE Purchase And Sale
-0.19
-408.11%
-0.04
+76.43%
-0.16
+10.29%
-0.17
Purchase Of PPE
-0.19
-408.11%
-0.04
+76.43%
-0.16
+19.07%
-0.19
Sale Of PPE
—
—
0.00
-100.00%
0.02
Capital Expenditure
-0.19
-408.11%
-0.04
+76.43%
-0.16
+19.07%
-0.19
Net Business Purchase And Sale
—
—
0.00
+100.00%
-5.00
Purchase Of Business
—
—
0.00
+100.00%
-5.00
Financing Cash Flow
6.63
-14.67%
7.77
+2132.47%
0.35
0.00
Cash Flow From Continuing Financing Activities
6.63
-14.67%
7.77
+2132.47%
0.35
0.00
Net Issuance Payments Of Debt
-1.32
-6.00%
-1.25
-299.36%
-0.31
0.00
Issuance Of Debt
1.93
0.00
—
—
Repayment Of Debt
-3.25
-160.00%
-1.25
-299.36%
-0.31
0.00
Long Term Debt Issuance
1.93
0.00
—
—
Long Term Debt Payments
-3.25
-160.00%
-1.25
-299.36%
-0.31
0.00
Net Long Term Debt Issuance
-1.32
-6.00%
-1.25
-299.36%
-0.31
0.00
Net Common Stock Issuance
4.10
-54.56%
9.02
+1264.45%
0.66
0.00
Proceeds From Stock Option Exercised
3.86
0.00
—
0.00
Changes In Cash
-5.36
-153.55%
-2.11
+82.18%
-11.86
+40.28%
-19.86
Effect Of Exchange Rate Changes
0.04
+216.13%
-0.03
-29.17%
-0.02
-33.33%
-0.02
Beginning Cash Position
6.49
-24.83%
8.64
-57.91%
20.52
-49.20%
40.41
End Cash Position
1.17
-82.00%
6.49
-24.83%
8.64
-57.91%
20.52
Free Cash Flow
-11.99
-21.31%
-9.88
+19.06%
-12.21
+17.95%
-14.88
Interest Paid Supplemental Data
0.12
-35.16%
0.18
-4.71%
0.19
+51.59%
0.13
Income Tax Paid Supplemental Data
0.01
-37.50%
0.01
-82.22%
0.04
+246.15%
0.01
Common Stock Issuance
4.10
-54.56%
9.02
+1264.45%
0.66
0.00
Issuance Of Capital Stock
4.10
-54.56%
9.02
+1264.45%
0.66
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category